How to buy Mediclinic International shares | 265.8p

Own Mediclinic International shares in just a few minutes.

Fact checked

Mediclinic International plc (MDC) is a leading medical care facilities business based in the UK. It opened the day at 270p after a previous close of 270.6p. During the day the price has varied from a low of 261.2p to a high of 270p. The latest price was 265.8p (25 minute delay). Mediclinic International is listed on the London Stock Exchange (LSE) and employs 34,262 staff. All prices are listed in pence sterling.

How to buy shares in Mediclinic International

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MDC in this case.
  5. Research Mediclinic International shares. The platform should provide the latest information available.
  6. Buy your Mediclinic International shares. It's that simple.

How has Coronavirus impacted Mediclinic International's share price?

Since the stock market crash in March caused by coronavirus, Mediclinic International's share price has had significant negative movement.

Its last market close was 267p, which is 31.56% down on its pre-crash value of 390.1p and 7.32% up on the lowest point reached during the March crash when the shares fell as low as 248.8p.

If you had bought £1,000 worth of Mediclinic International shares at the start of February 2020, those shares would have been worth £724.75 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £713.53.

Mediclinic International share price

Use our graph to track the performance of MDC stocks over time.

Mediclinic International shares at a glance

Information last updated 2020-08-14.
Open270p
High270p
Low261.2p
Close265.8p
Previous close270.6p
Change -4.8p
Change % -1.774%
Volume 324,927
Information last updated 2020-09-23.
52-week range232.4p - 419.4p
50-day moving average 263.4743p
200-day moving average 269.7879p
Wall St. target price448p
PE ratio 22.731
Dividend yield 0.08p (2.96%)
Earnings per share (TTM) 17.1p
Promoted
eToro Free Stocks

Invest in Mediclinic International shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Your first 50 trades are free with Fineco, until 30/09/2020. T&Cs apply. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

Is it a good time to buy Mediclinic International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Mediclinic International price performance over time

Historical closes compared with the last close of 265.8p

3 months (2020-06-24) 4.73%
6 months (2020-03-24) -8.97%

Is Mediclinic International under- or over-valued?

Valuing Mediclinic International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mediclinic International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mediclinic International's P/E ratio

Mediclinic International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Mediclinic International shares trade at around 23x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Mediclinic International's EBITDA

Mediclinic International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £479 million.

The EBITDA is a measure of a Mediclinic International's overall financial performance and is widely used to measure a its profitability.

Mediclinic International financials

Revenue TTM £3.1 billion
Operating margin TTM 10.51%
Gross profit TTM £1.1 billion
Return on assets TTM 3.03%
Return on equity TTM -9.54%
Profit margin -10.38%
Book value 3.92p
Market capitalisation £2 billion

TTM: trailing 12 months

Mediclinic International's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Mediclinic International.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Mediclinic International's total ESG risk score

Total ESG risk: 22.08

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Mediclinic International's overall score of 22.08 (as at 08/01/2020) is pretty good – landing it in it in the 34th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Mediclinic International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Mediclinic International's environmental score

Environmental score: 0.69/100

Mediclinic International's environmental score of 0.69 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Mediclinic International's social score

Social score: 11.99/100

Mediclinic International's social score of 11.99 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Mediclinic International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Mediclinic International's governance score

Governance score: 8.4/100

Mediclinic International's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Mediclinic International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Mediclinic International's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Mediclinic International scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Mediclinic International has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Mediclinic International plc was last rated for ESG on: 2020-08-01.

Total ESG score 22.08
Total ESG percentile 33.62
Environmental score 0.69
Environmental score percentile 3
Social score 11.99
Social score percentile 3
Governance score 8.4
Governance score percentile 3
Level of controversy 2

Mediclinic International share dividends

46%

Dividend payout ratio: 46.2% of net profits

Recently Mediclinic International has paid out, on average, around 46.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.96% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mediclinic International shareholders could enjoy a 2.96% return on their shares, in the form of dividend payments. In Mediclinic International's case, that would currently equate to about 0.08p per share.

While Mediclinic International's payout ratio might seem fairly standard, it's worth remembering that Mediclinic International may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 5 December 2019 (the "ex-dividend date").

Mediclinic International share price volatility

Over the last 12 months, Mediclinic International's shares have ranged in value from as little as 232.4p up to 419.4p. A popular way to gauge a stock's volatility is its "beta".

MDC.LSE volatility(beta: 0.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Mediclinic International's is 0.8021. This would suggest that Mediclinic International's shares are less volatile than average (for this exchange).

Mediclinic International overview

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 hospitals, 2 day case clinics, 3 outpatient clinics, and 110 theatres with approximately 1,893 inpatient beds in Switzerland; 52 hospitals, 10 day case clinics, 8 sub-acute hospitals, and 305 theatres in South Africa and Namibia with approximately 8,792 inpatient beds; and 7 hospitals, 2 day case clinics, 18 outpatient clinics, and 38 theatres with approximately 927 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site